CYREN holds a
performance score of 10 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -0.4034, which signifies possible diversification benefits within a given portfolio. Let's try to break down what CYREN's beta means in this case. As returns on the market increase, returns on owning CYREN are expected to decrease at a much lower rate. During the bear market, CYREN is likely to outperform the market. Although it is vital to follow
CYREN historical returns, it is good to be conservative about what you can do with the information regarding equity current trending patterns. Our philosophy in foreseeing
future performance of any stock is to look not only at its past charts but also at the business as a whole, including all fundamental and
technical indicators. To evaluate if CYREN expected return of 1.23 will be sustainable into the future, we have found twenty-one different
technical indicators, which can help you to check if the expected returns are sustainable. Use CYREN
standard deviation,
maximum drawdown, as well as the
relationship between the Maximum Drawdown and
expected short fall to analyze future returns on CYREN.
The successful prediction of Cyren
stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published
stock prices of traded companies, such as Cyren, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at
the intrinsic value of Cyren based on Cyren hews, social hype, general headline patterns, and widely used
predictive technical indicators. We also calculate exposure to Cyren's
market risk, different
technical and
fundamental indicators, relevant financial multiples and ratios, and then
comparing them to Cyren's related companies.
Watch out for price decline
Please consider monitoring Cyren on a daily basis if you are holding a position in it. Cyren is trading at a penny-stock level, and the possibility of delisting is much higher compared to other delisted stocks. However, just because the stock is trading under one dollar, does not mean it will be marked for deletion.
Most exchanges require public instruments, such as Cyren stock to be traded above the $1 level to remain listed. If Cyren stock price falls below $1 for 30 consecutive trading days, the exchange can delist it. Once the company reaches this point, they will be sent an initial price violation notice directly from an exchange.
Use Technical Analysis to project Cyren expected Price
Cyren technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Cyren technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Cyren trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions.
More Info...A Deeper Perspective
The company reported the previous year's revenue of 38.38
M. Net Loss for the year was (16.19
M) with profit before overhead, payroll, taxes, and interest of 23.06
M.
Deferred Revenue Breakdown
CYREN Deferred Revenue yearly trend continues to be quite stable with very little volatility. The value of Deferred Revenue is projected to decrease to about 7.9
M. Deferred Revenue usually refers to a component of Total Liabilities representing the carrying amount of consideration received or receivable on potential earnings that were not recognized as revenue; including sales; license fees; and royalties; but excluding interest income. CYREN Deferred Revenue is quite stable at the moment as compared to the past year. The company's current value of Deferred Revenue is estimated at 7.95 Million
| 2013 | 6.14 Million |
| 2014 | 5.14 Million |
| 2015 | 4.09 Million |
| 2016 | 6.4 Million |
| 2017 | 5.56 Million |
| 2018 | 6.28 Million |
| 2019 | 9.16 Million |
| 2020 | 7.95 Million |
Over 3 percent rise for CYREN. What does it mean for institutional investors?
The coefficient of variation is down to 684.47 as of today. CYREN is displaying above-average volatility over the selected time horizon. Investors should scrutinize CYREN independently to ensure intended market timing strategies are aligned with expectations about CYREN volatility.
Our Final Take On CYREN
Whereas some other companies within the security software & services industry are still a little expensive, even after the recent corrections, CYREN may offer a potential longer-term growth to institutional investors. To summarize, as of the 12th of August 2020, our primary 30 days buy-or-sell advice on the company is
Cautious Hold. We believe CYREN is
undervalued with
quite high probability of bankruptcy for the next two years.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Raphi Shpitalnik is a Junior Member of Macroaxis Editorial Board. Raphael is a young entrepreneur who joined Macroaxis on a part-time basis at the beginning of the pandemic and eventually acquired a real taste for investing and fintech. He likes to analyze different equity instruments across a wide range of industries, focusing primarily on consumer products, sports, fintech, cannabis, and AI.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Cyren. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com
